Los Angeles Business from bizjournals -- Peregrine Pharmaceuticals Inc. has been granted an additional three months by the NASDAQ to regain compliance with the exchange’s minimum bid price rule.
Los Angeles Business from bizjournals -- Peregrine Pharmaceuticals Inc. has been granted an additional three months by the NASDAQ to regain compliance with the exchange’s minimum bid price rule.
